By influencing numerous biological pathways, GLP-1 RAs may affect several important hallmarks of aging
Lack of Approved Indication: There is no approved indication for using GLP-1 agonists specifically for treating lipedema
An expert endocrinologist with proficiency in both general and sub-speciality endocrinology, he has an interest in longevity through improving cardiovascular risk, metabolism, bone health, and muscle loss prevention, with the ultimate aim of improving the number of healthy years in one's life
Emerging advancements in anti-obesity treatments include the development of oral formulations [23] and once-monthly [24] dosing regimens, which aim to improve patient adherence and convenience, simplifying the integration of these therapies into daily life
To meet different consumer needs companies are adding more options